METHOD FOR TREATING NYSTAGMUS AND AMBLYOPIS

FIELD: ophthalmology. SUBSTANCE: magnetic fields with intensity of 0.25 Tl are applied onto upper and temporal portions of eye's orbit onto auriculo-temporal region at chiasma projection level, and onto projection region of visual analyzers located on occipital tubers. Field parameters are sync...

Full description

Saved in:
Bibliographic Details
Main Authors LINNIK L.F, ANTROPOV G.M, BOLDYSHEVA I.A, OGLEZNEVA O.K, ERMILOVA I.A
Format Patent
LanguageEnglish
Published 10.02.1998
Edition6
Subjects
BANDAGES, DRESSINGS OR ABSORBENT PADS
DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS
ELECTROTHERAPY
FILTERS IMPLANTABLE INTO BLOOD VESSELS
FIRST-AID KITS
FOMENTATION
HUMAN NECESSITIES
HYGIENE
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES
PROSTHESES
RADIATION THERAPY
TREATMENT OR PROTECTION OF EYES OR EARS
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:FIELD: ophthalmology. SUBSTANCE: magnetic fields with intensity of 0.25 Tl are applied onto upper and temporal portions of eye's orbit onto auriculo-temporal region at chiasma projection level, and onto projection region of visual analyzers located on occipital tubers. Field parameters are synchronized with pulsed wave of internal carotid. Fields are applied simultaneously onto identical-sign regions, field vectors with one and the same direction. Each region is exposed for 5-10 min, treatment course including 10-15 procedures. EFFECT: improved visual function; reduced nystagmus amplitude. 2 tbl
Bibliography:Application Number: RU19930016150